ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit from October 31 till November 2 in Boston.
Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step in the development of therapeutic antibodies. However, humanization is still characterized by a high risk as affinity and specificity can be lost during the humanization process.
ModiQuest Research will present a full antibody engineering platform (ModiTuneTM) to obtain humanized antibodies with similar affinity and specificity as the original antibody.
Meet Jos Raats (CEO) and Nienke Smits (Business development) at booth #55 or at our poster to discover our state of the art antibody generation and engineering platforms and to discuss your specific antibody projects.
If you have any questions, inquiries or if you would like to arrange a meeting during the event, please don’t hesitate to contact us. Mail to: or call us on +31 412 846 000 to fix a time to talk.
Hope to meet you at the European Antibody Congress in Basel!

Jos Raats and Nienke Smits

Nienke Smits (